Neurotensin receptor agonists and antagonists for schizophrenia

Am J Psychiatry. 2005 Mar;162(3):633-4; author reply 635. doi: 10.1176/appi.ajp.162.3.633-b.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Animals
  • Antipsychotic Agents / therapeutic use*
  • Blood-Brain Barrier / drug effects
  • Clinical Trials as Topic
  • Drugs, Investigational / pharmacokinetics
  • Drugs, Investigational / therapeutic use
  • Humans
  • Neurotensin / analogs & derivatives*
  • Neurotensin / pharmacokinetics
  • Neurotensin / therapeutic use*
  • Peptide Fragments / pharmacokinetics
  • Peptide Fragments / therapeutic use*
  • Pyrazoles / therapeutic use
  • Quinolines / therapeutic use
  • Receptors, Neurotensin / agonists*
  • Receptors, Neurotensin / antagonists & inhibitors
  • Schizophrenia / drug therapy*
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Drugs, Investigational
  • Peptide Fragments
  • Pyrazoles
  • Quinolines
  • Receptors, Neurotensin
  • neurotensin 69L
  • SR 48692
  • Neurotensin